Results 21 to 30 of about 15,305 (301)

Synergy between the pay‐for‐performance scheme and better physician–patient relationship might reduce the risk of retinopathy in patients with type 2 diabetes

Journal of Diabetes Investigation, 2021
Aims/Introduction This study investigated whether participation by patients with type 2 diabetes in Taiwan’s pay‐for‐performance (P4P) program and maintaining good continuity of care (COC) with their healthcare provider reduced the likelihood of future ...
Shang‐Jyh Chiou, Kuomeng Liao, Yu‐Tung Huang, Wender Lin, Chi‐Jeng Hsieh   +4 more
doaj   +1 more source

The effect of ‘paying for performance’ on the management of type 2 diabetes mellitus: a cross-sectional observational study

BJGP Open, 2020
Background: The ‘cycle of care’ (COC) pay for performance (PFP) programme, introduced in 2015, has resourced Irish GPs to provide structured care to PCRS eligible patients with type 2 diabetes mellitus (T2DM).
Raymond O'Connor, Rory O'Driscoll, Jane O'Doherty, Ailish Hannigan, Aoife O'Neill, Conor Teljeur, Andrew O'Regan   +6 more
doaj   +1 more source

How can Saudi Arabia reform its public hospital payment models? A narrative review

Saudi Pharmaceutical Journal, 2020
Background: The cost of Saudi healthcare continues to rise at an alarming rate, putting the sustainability of the public healthcare system into question.
Yazed AlRuthia, Norah Abdulaziz Bin Aydan, Nora Sulaiman Alorf, Yousif Asiri   +3 more
doaj   +1 more source

Early Enrollment in Diabetes Pay-for-Performance Program Reduced Loss of Life Expectancy in Newly-Diagnosed Patients with Type 2 Diabetes Mellitus [PDF]

Diabetes & Metabolism Journal
Background Diabetes is associated with reduced lifespan. To explore pay-for-performance (P4P) program and life expectancy (LE), we investigated the impact of interval between diabetes diagnosis and enrollment in P4P program on loss-of-LE among patients ...
Yu-Ching Chen, Wei-Ming Wang, Boniface J. Lin, Jung-Der Wang, Li-Jung Elizabeth Ku   +4 more
doaj   +1 more source

Recent advances in addressing the market failure of new antimicrobials: Learnings from NICE's subscription-style payment model

Frontiers in Medical Technology, 2023
BackgroundAntimicrobial resistance (AMR) is a growing threat to global health. With pathogenic bacteria inevitably becoming more resistant to existing antimicrobials, mortality and costs due to AMR will significantly increase over the next few decades if
Marieke Schurer, Renu Patel, Marjolijn van Keep, Jake Horgan, Suzette Matthijsse, Matthew Madin-Warburton   +5 more
doaj   +1 more source

Understanding the Public Policy of Global Budget Payment Reform Improves the Quality of Public Healthcare From the Perspective of Patients in China

Frontiers in Psychology, 2022
The transformation from the retrospective to the prospective payment system is significant to improve the quality of public healthcare (QPH). This article used the quasi-natural experiment of the global budget payment reform of government (GBPRG) in ...
Lele Li, Shuo Zhang
doaj   +1 more source

sj-pdf-1-mcr-10.1177_10775587221139516 – Supplemental material for How Do Primary Care Providers Respond to Reimbursement Cuts? Evidence From the Termination of the Primary Care Incentive Program

, 2022
Supplemental material, sj-pdf-1-mcr-10.1177_10775587221139516 for How Do Primary Care Providers Respond to Reimbursement Cuts? Evidence From the Termination of the Primary Care Incentive Program by Christopher S.
Christopher S. Brunt (14274933)
core   +1 more source

Incentives and Pharmaceutical Reimbursement Reforms in Spain [PDF]

SSRN Electronic Journal, 2003
The aim of this paper is to assess whether cost containment has been affected by recent pharmaceutical reimbursement reforms that have been introduced in the Spanish health care system over the period 1996-2002, under the conservative Popular Party Government.
openaire   +4 more sources

An empirical study of the impact of generic drug competition on drug market prices in China

Frontiers in Public Health, 2023
IntroductionGeneric substitution is encouraged to reduce pharmaceutical spending in China, and with incentive policies, the market size of the generic drug continues to rise.
Chen Yina, Liu Pengcheng, Nie Haomiao, Cao Yang   +3 more
doaj   +1 more source

Envisioning Post-pandemic Digital Neurological, Psychiatric and Mental Health Care

Frontiers in Digital Health, 2021
The SARS-Cov-2 pandemic placed a dramatic burden on managed healthcare and perhaps nowhere as evident as in neurological and psychiatric disease care.
Amit Khanna, Graham B. Jones, Graham B. Jones   +2 more
doaj   +1 more source